Contents of this document
- Capital and business alliance with ONTO Innovation scheduled to close in the second half
- RTC-China (Shanghai) scheduled to open during FY2026
- Development and launch of strategic products for next-generation semiconductors
- Start of joint development of the CD-SAXS-OCD Hybrid Engine
- Q2 order growth rate (consolidated)>50Year on year against the same period last yearMore than +50%
- First-half order growth rate (consolidated)>25Year on year against the same period last yearMore than +25%
- Pipeline growth rate>35Year on yearMore than +35%
- First-half order growth rate for semiconductor process control equipment86 %Year on year against the same period last year+86%
- New JEP FY26 projects commenced5 Projects
- Estimated SAM for strategic products$10 100 million
- Target share for strategic products50 Over %
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending December 2026 (first half) |
| Net Sales | ¥395 100 million (first half) (YoY -2.9%) |
| Operating profit | ¥25 100 million (first half) (YoY -54.9%) |
| Net income | ¥16 100 million (first half; interim profit) (YoY -56.9%) |
| Gross Profit Margin | Down 7.5 percentage points year on year (stated as an explanation of the operating margin; the actual gross margin is Not disclosed) |
| Operating profit margin | 6.5 % (first half) |
| Results for the three months of the current quarter | Revenue 216 Hundreds of millions of yen (YoY +7.4%) / Operating profit 19 Hundreds of millions of yen (YoY -32.4%) / Income before taxes 16 Hundreds of millions of yen (YoY -39.6%) / Quarterly profit 12 Hundreds of millions of yen (YoY -30.2%) / Operating profit margin 9 % |
| Full-year earnings forecast | Revenue 1,010 Hundreds of millions of yen / Operating profit 194 Hundreds of millions of yen / Income before taxes 184 Hundreds of millions of yen / Profit for the period 125 Hundreds of millions of yen / Basic EPS ¥55.27 / EBITDA 253 Hundreds of millions of yen / Operating profit margin 19.3 % / EBITDA margin 25.1 % |
| Self-assessment against the plan | The first half was broadly in line with the plan. Semiconductor process control equipment is progressing ahead of plan. |
| Segment results | Multi-purpose Analytical Instruments Revenue 150 Hundreds of millions of yen (YoY -17.1%) / Operating profit 0 Hundreds of millions of yen (YoY -98.6%) / Semiconductor Process Control Equipment Revenue 127 Hundreds of millions of yen (YoY +18.2%) / Operating profit 19 Hundreds of millions of yen (YoY -19.0%) / Parts and Services Revenue 116 Hundreds of millions of yen (YoY -0.5%) / Operating profit 16 Hundreds of millions of yen (YoY -22.7%) |
| Breakdown of Factors Affecting the Change | Year-on-year change in first-half operating margin Gross margin -1.0 pt; higher SG&A ratio due to lower sales -1.4 pt; R&D expenses -0.9 pt; personnel expenses -4.2 pt; other SG&A expenses, etc. -0.0 pt; foreign exchange loss +0.0 pt / Year-on-year change in Q2 operating margin Gross margin -0.2 pt; lower SG&A ratio due to higher sales +3.3 pt; R&D expenses -1.1 pt; personnel expenses -3.5 pt; distributor commissions -1.3 pt; other SG&A expenses, etc. -0.7 pt; foreign exchange loss +0.3 pt |
| Key KPIs | Indicator name Q2 order growth rate (consolidated) / Value >50 / Year on year against the same period last year More than +50%, Indicator name First-half order growth rate (consolidated) / Value >25 / Year on year against the same period last year More than +25%, Indicator name Pipeline growth rate / Value >35 / Year on year More than +35%, Indicator name First-half order growth rate for semiconductor process control equipment / Value 86 % / Year on year against the same period last year +86%, Indicator name New JEP FY26 projects commenced / Value 5 Projects / Year on year against the same period last year Not disclosed, Indicator name Estimated SAM for strategic products / Value $10 100 million / Year on year against the same period last year Not disclosed, Indicator name Target share for strategic products / Value 50 Over % / Year on year against the same period last year Not disclosed |
| Assumptions Underlying the Business Outlook | JPY/USD ¥145 /US$ / JPY/EURO 165 JPY/EUR / Sensitivity to US dollar exchange rates Revenue Approximately ¥200 million / Operating profit Approximately ¥40 million / Sensitivity to euro exchange rates Revenue Approximately ¥70 million / Operating profit Approximately ¥30 million |
| Medium-term management plan targets | Revenue growth Underlying growth of +9% company-wide, +4% for multipurpose analytical instruments and +21% for semiconductor process control equipment (initial guidance for the year) / 2030 revenue target Targeting revenue of ¥100 billion in 2030 / Target share for strategic products 50% or higher |
| Annual Dividend | Interim Dividend ¥9.5 / Year-end dividend Not disclosed / Annual Dividend Not disclosed |
| Capital expenditures | ¥29 100 million (first half) |
| Market Size / Share | X-ray Metrology Market Rigaku expanded its share and maintained its No. 1 position (figures of 498 and 532 shown for market size, etc.) / Film and Materials Metrology Market Rigaku increased its share to take the No. 1 position / Estimated SAM for strategic products Approximately US$1 billion |
| New initiatives | Capital and business alliance with ONTO Innovation scheduled to close in the second half, RTC-China (Shanghai) scheduled to open during FY2026, Development and launch of strategic products for next-generation semiconductors, Start of joint development of the CD-SAXS-OCD Hybrid Engine |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the first half, the gross margin for semiconductor process control equipment declined due to higher costs, including special factors in Q1, foreign exchange effects and upfront investments, while increases in R&D and personnel expenses from ongoing strategic investments also weighed on operating profit. In multipurpose analytical instruments, the downward trend in revenue in the academic sector has continued, delaying the recovery in sales compared with the initial plan for the year.